Invested Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$744K Sell
2,956
-191
-6% -$41.1K 0.66% 37
2026
Q1
$684K Sell
3,147
-37
-1% -$8.21K 0.69% 34
2025
Q4
$728K Buy
3,184
+244
+8% +$55.6K 0.75% 31
2025
Q3
$525K Buy
+2,940
New +$599K 0.76% 33

Other funds holding ABBV

Invested Advisors's ABBV Position: Q2 2026 in Review

Invested Advisors reduced its AbbVie (ABBV) stake by 6.1% in Q2 2026, selling an estimated $41.1K and leaving 2,956 shares worth $744K. The position accounts for 0.66% of the portfolio, ranked #37.

Invested Advisors first reported a position in ABBV in Q3 2025 and has held it in 4 quarters since. 2,495 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Invested Advisors held 2,956 shares of AbbVie worth $744K as of Q2 2026.
  • Invested Advisors sold 191 AbbVie shares in Q2 2026, an estimated $41.1K.
  • AbbVie made up 0.66% of Invested Advisors's portfolio in Q2 2026, its #37 holding.
  • Invested Advisors first reported a position in AbbVie in Q3 2025 and has held it in 4 quarters since.
  • 2,495 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Invested Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.